Stereospecific (3H)(minus)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase.
D000255:Adenosine Triphosphate; D000262:Adenylyl Cyclases / Q000097:blood*; D000526:Alprenolol / Q000097:blood* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001665:Binding Sites; D001667:Binding, Competitive; D002462:Cell Membrane / Q000378:metabolism; D002467:Cell Nucleus / Q000187:drug effects; D000242:Cyclic AMP; D004789:Enzyme Activation / Q000187:drug effects; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010761:Phosphorus Radioisotopes; D011433:Propranolol / Q000494:pharmacology; D011485:Protein Binding; D011941:Receptors, Adrenergic / Q000187:drug effects; D013237:Stereoisomerism; D014316:Tritium
D010761:Phosphorus Radioisotopes; D011941:Receptors, Adrenergic; D014316:Tritium; D000526:Alprenolol; D000255:Adenosine Triphosphate; D011433:Propranolol; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D009638:Norepinephrine; D010646:Phentolamine